Abstract

To use causal inference to investigate whether the flare or antagonist protocol is better for poor responders going through controlled ovarian stimulation. A retrospective study. Retrieval cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Patients in the United States underwent autologous invitro fertilization cycles from 2014 to 2019 using either the flare or antagonist protocol. Not applicable. Primary outcomes included oocytes retrieved, fertilized oocytes (2PNs), blastocysts, the cumulative live birth rate (CLBR), and cycle cancelation rate. After propensity score matching, patients with a predicted poor response (antimüllerian hormone, <0.5) on their first invitro fertilization cycle had similar outcomes on the antagonist protocol (CLBR of 14.2%, 95% confidence intervals [CIs]: 13.6%, 14.8%) compared with flare (CLBR of 13.6%, 95% CIs: 12.4%, 14.8%). We evaluated patients undergoing a second cycle after having a poor response (<4 oocytes retrieved) on their first cycle. Patients in the antagonist-to-antagonist group had a similar change in outcomes between the first and second cycles (average CLBR improvement of 13.9%, 95% CIs: 12.1%, 15.6%) compared with the antagonist-to-flare group (average CLBR improvement of 14.4%, 95% CIs: 10.9%, 18.3%). In addition, patients in the flare-to-antagonist group had a similar change in outcomes between the first and second cycles (average CLBR improvement of 10.4%, 95% CIs: 6.6%, 14.5%) compared with the flare-to-flare group (average CLBR improvement of 9.0%, 95% CIs: 5.1%, 13.4%). Poor responders have similar outcomes on an antagonist protocol compared with a flare protocol for both the first and second cycles.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call